Updates in SMA and Gene Therapy from Arlington, VA

Activity Info

Experts in spinal muscular atrophy and gene therapy discuss topics covered in a 2018 clinical conference held in Arlington, VA. New and emerging treatment options for SMA make early diagnosis and newborn screening critical for pediatric neurologists. Two experts discuss new information and perspectives on how gene therapy will affect clinical practice in managing patients with SMA.

This activity is hosted on MedPageToday.com. By clicking Begin Activity, you will be leaving The France Foundation website. Registration on MedPageToday.com may be required.


Pulmonary | CME (AMA PRA Category 1 Credit) | Gastroenterology | Genetic Counselor | Internal Medicine | Neurology | Neuromuscular Specialist | Pediatrics | Nurse | Nurse Practitioner | Ob/Gyn & Women's Health | Physical Medicine & Rehabilitation | Spinal Muscular Atrophy | Genomic Medicine | Neonatal/Perinatal  | Neurosurgery | Orthopedic Surgery |